Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3257481 | Clinical Immunology | 2009 | 5 Pages |
Abstract
Africans have elevated T cell activation compared to residents of Europe or the USA. Levels of T cell activation also correlate with disease progression in HIV-infected individuals. We sought to determine if treatment with antiretroviral therapy (ART) would reduce levels of T cell activation (CD38 and HLADR co-expression) in HIV-infected Ugandan children. The median CD8+ T cell activation level among 199 ART-treated children (30%) was lower than in 57 ART-naïve children (45%, p < 0.001), but remained higher than in 30 HIV-uninfected children (18%, p < 0.001). Among ART-treated children, CD4% was inversely correlated with both CD8â (Ï = â 0.61, p < 0.001) and CD8+ (Ï = â 0.38, p < 0.001) T cell activation. Prospectively, CD4 recovery correlated with post-treatment CD8+ T cell activation level (p = 0.008). Our data suggest that significant decreases in T cell activation accompany CD4 recovery in ART-treated HIV-infected African children, to levels that approach but do not reach those of uninfected children.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Theodore Ruel, Isaac Ssewanyana, Jane Achan, Anne Gasasira, Moses R. Kamya, Adeodata Kekitiinwa, Joseph K. Wong, Huyen Cao, Diane Havlir, Edwin D. Charlebois,